Advertisement
Screener

Humacyte, Inc. (HUMA) Other

Humacyte, Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-08-12: Form 10-Q; Item Stock registered under Section 12(b); As filed Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 · HUMAW · NASDAQ.
  • 2026-05-13: Form 10-Q; Item Stock registered under Section 12(b); As filed Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 · HUMAW · NASDAQ.
  • 2026-03-27: Form 10-K; Item Stock registered under Section 12(b); As filed Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 · HUMAW · NASDAQ.
  • 2025-11-12: Form 10-Q; Item Stock registered under Section 12(b); As filed Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 · HUMAW · NASDAQ.
FiledFormItemAs filed
2026-08-1210-QStock registered under Section 12(b)Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 · HUMAW · NASDAQ
2026-05-1310-QStock registered under Section 12(b)Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 · HUMAW · NASDAQ
2026-03-2710-KStock registered under Section 12(b)Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 · HUMAW · NASDAQ
2025-11-1210-QStock registered under Section 12(b)Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 · HUMAW · NASDAQ
2025-11-1210-QEmerging growth companyYes
2025-08-1110-QStock registered under Section 12(b)Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 · HUMAW · NASDAQ
2025-08-1110-QEmerging growth companyYes
2025-05-1310-QStock registered under Section 12(b)Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 · HUMAW · NASDAQ
2025-05-1310-QEmerging growth companyYes
2025-03-3110-KStock registered under Section 12(b)Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 · HUMAW · NASDAQ
2025-03-3110-KEmerging growth companyYes
2024-11-0810-QStock registered under Section 12(b)Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 · HUMAW · NASDAQ
2024-11-0810-QEmerging growth companyYes
2024-08-1310-QStock registered under Section 12(b)Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 · HUMAW · NASDAQ
2024-08-1310-QEmerging growth companyYes
2024-05-1310-QStock registered under Section 12(b)Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 · HUMAW · NASDAQ
2024-05-1310-QEmerging growth companyYes
2024-03-2810-KStock registered under Section 12(b)Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 · HUMAW · NASDAQ
2024-03-2810-KEmerging growth companyYes
2023-11-0910-QStock registered under Section 12(b)Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 · HUMAW · NASDAQ
2023-11-0910-QEmerging growth companyYes
2023-08-1410-QStock registered under Section 12(b)Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 · HUMAW · NASDAQ
2023-08-1410-QEmerging growth companyYes
2023-05-1210-QStock registered under Section 12(b)Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 · HUMAW · NASDAQ
2023-05-1210-QEmerging growth companyYes
2023-03-2410-KStock registered under Section 12(b)Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 · HUMAW · NASDAQ
2023-03-2410-KEmerging growth companyYes
2022-11-1010-QStock registered under Section 12(b)Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 · HUMAW · NASDAQ
2022-11-1010-QEmerging growth companyYes
2022-08-1210-QStock registered under Section 12(b)Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 · HUMAW · NASDAQ
2022-08-1210-QEmerging growth companyYes
2022-05-1310-QStock registered under Section 12(b)Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 · HUMAW · NASDAQ
2022-05-1310-QEmerging growth companyYes
2022-03-2910-KStock registered under Section 12(b)Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 · HUMAW · NASDAQ
2022-03-2910-KEmerging growth companyYes
2021-11-1510-QStock registered under Section 12(b)Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 · HUMAW · NASDAQ
2021-11-1510-QEmerging growth companyYes
2021-08-1610-QShares outstanding CommonClassA as of 2021-08-1610,355,000
2021-08-1610-QShares outstanding CommonClassB as of 2021-08-162,500,000
2021-08-1610-QStock registered under Section 12(b)Class A Common Stock, par value $0.0001 per share · AHACU · NASDAQ
2021-08-1610-QShell companyYes
2021-08-1610-QEmerging growth companyYes
2021-08-1610-QCurrent in its reportingNo
2021-05-1710-QShell companyYes
2021-05-1710-QEmerging growth companyYes
2021-05-1710-QCurrent in its reportingNo
2021-05-1410-K/AShell companyYes
2021-05-1410-K/AEmerging growth companyYes
2021-02-1610-KShell companyYes
2021-02-1610-KEmerging growth companyYes
2020-11-1310-QShell companyYes
2020-11-1310-QCurrent in its reportingNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
Voyager Therapeutics, Inc. (VYGR)United States$0.173B-1.99
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48
enGene Therapeutics Inc. (ENGN)$0.129B-0.92
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63